Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06626737
What this trial is testing

Dapagliflozin in Allo-HCT for aGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University 72
Not applicableUnknownNCT03659084
What this trial is testing

Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Hospices Civils de Lyon 150
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableLooking for participantsNCT06946654
What this trial is testing

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Who this might be right for
ElderlyGeriatric AssessmentALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital 176
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Not applicableActive Not RecruitingNCT04217356
What this trial is testing

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

Who this might be right for
MyelofibrosisHigh-Risk CancerBone Marrow Cancer
University Health Network, Toronto 90
Testing effectiveness (Phase 2)Ended earlyNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 2
Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Testing effectiveness (Phase 2)Ended earlyNCT01773395
What this trial is testing

GVAX vs. Placebo for MDS/AML After Allo HSCT

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Dana-Farber Cancer Institute 123
Not applicableUnknownNCT05649371
What this trial is testing

Multiphasic Prehab Allo-HSCT

Who this might be right for
Leukemia
University of Calgary 60
Testing effectiveness (Phase 2)UnknownNCT04809181
What this trial is testing

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
First Affiliated Hospital of Zhejiang University 95
Very early researchLooking for participantsNCT06633328
What this trial is testing

CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Zhejiang University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07315165
What this trial is testing

Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)
University of Nebraska 112
Testing effectiveness (Phase 2)Looking for participantsNCT05682755
What this trial is testing

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, Acute
Sichuan University 77
Testing effectiveness (Phase 2)Study completedNCT03678493
What this trial is testing

FMT in Patients With AML Allo HSCT in Recipients

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Cell Transplantation
Masonic Cancer Center, University of Minnesota 100
Testing effectiveness (Phase 2)Ended earlyNCT03343600
What this trial is testing

Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 5
Testing effectiveness (Phase 2)Looking for participantsNCT07606703
What this trial is testing

A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT

Who this might be right for
Chronic Graft-Versus-Host DiseaseGraft vs Host Disease
WeiShi 30
Large-scale testing (Phase 3)Study completedNCT06791746
What this trial is testing

Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT

Who this might be right for
Stem Cell Transplant ComplicationsOral Mucositis
Zhejiang University 388
Not applicableEnrolling By InvitationNCT06912347
What this trial is testing

Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in Allo-HSCT Patients

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital 180
Large-scale testing (Phase 3)UnknownNCT03662087
What this trial is testing

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Who this might be right for
Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
Nanfang Hospital, Southern Medical University 100
Next Page
45